Mimedx (MDXG) Gross Profit (2011 - 2026)

Mimedx has disclosed Gross Profit across 16 years of filings, most recently posting $44.4 million for Q2 2026.

• In Q2 2026, Gross Profit fell 44.47% year-over-year to $44.4 million; the TTM figure through Jun 2026 stood at $280.0 million (down 5.49% YoY), while the FY2025 annual figure was $345.6 million, up 19.67% from the prior year.
• Gross Profit came in at $44.4 million for Q2 2026 at Mimedx, up from $41.6 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $99.0 million in Q4 2025 to a low of $41.6 million in Q1 2026.
• Average Gross Profit over 5 years is $67.0 million, with a median of $68.2 million recorded in 2023.
• Year-over-year, Gross Profit jumped 38.22% in 2025 and tumbled 44.47% in 2026.
• Over 5 years, Gross Profit stood at $60.0 million in 2022, then gained by 21.64% to $73.0 million in 2023, then advanced by 4.12% to $76.0 million in 2024, then soared by 30.32% to $99.0 million in 2025, then plunged by 55.19% to $44.4 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $44.4 million in Q2 2026, $41.6 million in Q1 2026, and $99.0 million in Q4 2025.